Core Viewpoint - Encompass Health (EHC) reported quarterly earnings of $1.46 per share, exceeding the Zacks Consensus Estimate of $1.29 per share, and showing an increase from $1.17 per share a year ago, indicating a positive earnings surprise of +12.95% [1] Financial Performance - The company achieved revenues of $1.54 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.23% and up from $1.41 billion year-over-year [2] - Over the last four quarters, Encompass Health has consistently exceeded consensus EPS estimates and revenue estimates [2] Stock Performance - Encompass Health shares have declined approximately 9.9% since the beginning of the year, contrasting with the S&P 500's gain of 0.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.50 on revenues of $1.58 billion, and for the current fiscal year, it is $5.81 on revenues of $6.44 billion [7] - The trend of earnings estimate revisions for Encompass Health was mixed prior to the earnings release, which may influence future stock performance [6] Industry Context - The Medical - Outpatient and Home Healthcare industry, to which Encompass Health belongs, is currently ranked in the bottom 35% of over 250 Zacks industries, suggesting potential challenges ahead [8]
Encompass Health (EHC) Q4 Earnings and Revenues Top Estimates